Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations

The first liposomal formulation of cisplatin to be evaluated clinically was SPI-077. Although the formulation demonstrated enhanced cisplatin tumor accumulation in preclinical models it did not enhance clinical efficacy, possibly due to limited cisplatin release from the formulation localized within...

Descripción completa

Detalles Bibliográficos
Autores principales: Zisman, Natalia, Dos Santos, Nancy, Johnstone, Sharon, Tsang, Alan, Bermudes, David, Mayer, Lawrence, Tardi, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265247/
https://www.ncbi.nlm.nih.gov/pubmed/22312548
http://dx.doi.org/10.1155/2011/213848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265247/
https://www.ncbi.nlm.nih.gov/pubmed/22312548
http://dx.doi.org/10.1155/2011/213848

Ejemplares similares